QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
CVE:EMH

Emerald Health Therapeutics (EMH) Stock Forecast, Price & News

C$0.26
-0.01 (-3.77%)
(As of 04/26/2021)
Compare
Today's Range
C$0.25
C$0.27
50-Day Range
C$0.26
C$0.26
52-Week Range
C$0.15
C$0.53
Volume
384,329 shs
Average Volume
644,760 shs
Market Capitalization
C$52.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

EMH stock logo

About Emerald Health Therapeutics (CVE:EMH) Stock

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EMH Stock News Headlines

Emerald Care Center Tulsa
Emerald Reeg
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Emerald Health Therapeutics Inc (TBD.BE)
[BREAKING] New "Living Software" to Revolutionize Warfare
This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>
Emperor Oil Ltd (EMh)
Stocks in play: Emerald Health Therapeutics Inc
Emerald Health Therapeutics Reports 2021 AGM Results
Avricore Health Inc
EMERALD HEALTH THER. (TBD.BE)
See More Headlines

EMH Price History

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
161
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$13.02 million
Cash Flow
C$0.33 per share
Book Value
C$0.40 per share

Miscellaneous

Free Float
N/A
Market Cap
C$52.28 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Avtar S. Dhillon (Age 59)
    Exec. Chairman
    Comp: $485.05k
  • Mr. Riaz Bandali M.B.A. (Age 51)
    CEO & Pres
    Comp: $428.21k
  • Ms. Jenn Hepburn B.B.A.
    CFO & Company Sec.
  • Mr. Orville Bovenschen
    Sr. VP of Operations
  • Mr. Bernie Hertel
    VP of Fin. and Communications
  • Ms. Rebecca Wong
    Sr. VP of Quality & Regulatory Affairs













EMH Stock - Frequently Asked Questions

How have EMH shares performed in 2023?

Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of the year. Since then, EMH shares have increased by 0.0% and is now trading at C$0.26.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), Organigram (OGI), Emerald Health Therapeutics (EMHTF).

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Emerald Health Therapeutics' stock price today?

One share of EMH stock can currently be purchased for approximately C$0.26.

How much money does Emerald Health Therapeutics make?

Emerald Health Therapeutics (CVE:EMH) has a market capitalization of C$52.28 million and generates C$13.02 million in revenue each year.

How many employees does Emerald Health Therapeutics have?

The company employs 161 workers across the globe.

How can I contact Emerald Health Therapeutics?

Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The official website for the company is www.emerald.care. The company can be reached via phone at +1-250-8189838.

This page (CVE:EMH) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -